By A essential care nurse in New York Metropolis is the primary particular person in the USA to obtain the brand new Pfizer-BioNTech vaccine towards COVID-19.
Sandra Lindsay, a essential care nurse at Lengthy Island Jewish Medical Heart in Queens, acquired the primary dose on Monday morning, Axios stated.
At the moment, the primary shipments of two.9 million doses of the vaccine are on their technique to states and hospitals. By the top of December an estimated 20 million individuals shall be vaccinated, and by the top of January one other 30 million will get the vaccine.
HIMSS20 Digital
Be taught on-demand, earn credit score, discover merchandise and options. Get Began >>
Vaccines shall be given first to frontline healthcare employees and susceptible populations in long-term care amenities. The vaccine is predicted to exit to long-term care amenities on Monday, Dec. 21.
The federal authorities is sending $140 million to states to assist fund distribution operations, based on HHS Secretary Alex Azar.
Insurers are dealing with administration prices.
The vaccine goes to 636 websites nationwide at the moment, over 400 tomorrow and can proceed, till, by the top of second quarter 2021, there shall be sufficient vaccine to vaccinate all who need it, Azar stated.
The vaccine, which has proven 95% efficacy in safety towards the coronavirus, acquired Meals and Drug Administration approval on Friday evening after the FDA’s advisory committee accepted its emergency use authorization.
As well as, the Division of Well being and Human Providers and the Division of Protection introduced Friday that the federal authorities will buy an extra 100 million doses of the COVID-19 vaccine from Moderna.
The FDA advisory committee will meet to overview the Moderna vaccine for EAU on Thursday, December 17.
See our persevering with vaccine protection right here:
Pfizer-BioNTech vaccine will get FDA advisory committee approval
CMS affords steerage in billing Medicare for COVID-19 antibody therapy
1000’s in the UK are the primary to obtain Pfizer COVID-19 vaccine
Eli Lilly and UnitedHealth Group associate on COVID-19 antibody therapy for high-risk people
Operation Warp Velocity is seeking to begin distributing COVID-19 vaccine by mid-month
Moderna seeks regulatory authorization for its COVID-19 vaccine
HHS will start allocating Regeneron’s COVID-19 therapeutic this week
HHS companions with chain and unbiased pharmacies to extend entry to future COVID-19 vaccines
COVID-19 vaccine distribution will start inside 24 hours of an emergency use authorization
Moderna vaccine candidate exhibits 94.5% efficacy towards COVID-19
Pfizer touts new COVID-19 vaccine, calling it ‘90% efficient’
Medicare beneficiaries can get monoclonal antibody COVID-19 therapies without charge
FDA grants emergency use authorization for Eli Lilly antibody therapy for COVID-19
Twitter: @SusanJMorse
Electronic mail the author: susan.morse@himssmedia.com
